Poseida Therapeutics

Poseida Therapeutics

Poseida Therapeutics

Poseida Therapeutics is translating bestinclass gene editing technologies into lifesaving treatments and developing CAR Tcell immunotherapies for cancer
Raised
$172.5M
Follow us
Alexa global traffic share
Twitter followers
22 Apr 2019
$142,000,000
Venture capital (Series C)
04 Apr 2018
$30,500,000
Venture capital (Series B)

Poseida Therapeutics snags $30.5 mln Series B

PE HUB
+2